======= JAZF1 =======
== Gene Information ==
* **Official Symbol**: JAZF1
* **Official Name**: JAZF zinc finger 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=221895|221895]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q86VZ6|Q86VZ6]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=JAZF1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20JAZF1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/606246|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a nuclear protein with three C2H2-type zinc fingers, and functions as a transcriptional repressor. Chromosomal aberrations involving this gene are associated with endometrial stromal tumors. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Acts as a transcriptional corepressor of orphan nuclear receptor NR2C2 (PubMed:15302918). Inhibits expression of the gluconeogenesis enzyme PCK2 through inhibition of NR2C2 activity (By similarity). Also involved in transcriptional activation of NAMPT by promoting expression of PPARA and PPARD (By similarity). Plays a role in lipid metabolism by suppressing lipogenesis, increasing lipolysis and decreasing lipid accumulation in adipose tissue (By similarity). Plays a role in glucose homeostasis by improving glucose metabolism and insulin sensitivity (By similarity). {ECO:0000250|UniProtKB:Q80ZQ5, ECO:0000269|PubMed:15302918}.
No Pfam Domain information is available for this gene.
|transcriptional repressor complex|
|fibrillar center|
|nucleic acid binding|
|transcription corepressor activity|
|negative regulation of transcription by RNA polymerase II|
|negative regulation of transcription, DNA-templated|
|lipid metabolic process|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|negative regulation of gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp521|Salinomycin 3.5μM R08 exp521]]|1.7|
|[[:results:exp111|R-DABN 8μM R03 exp111]]|1.95|
|[[:results:exp256|HMS-I1 10μM R06 exp256]]|2.26|
|[[:results:exp33|Rotenone 2μM R00 exp33]]|2.33|
|[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|2.7|
|[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|2.79|
|[[:results:exp244|SB743921 0.001μM R05 exp244]]|2.82|
|[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|3.04|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 347/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|1/1|
|909776.0|0/1|
|bile duct|18/28|
|blood|17/28|
|bone|12/25|
|breast|21/33|
|central nervous system|31/56|
|cervix|1/4|
|colorectal|11/17|
|esophagus|5/13|
|fibroblast|1/1|
|gastric|6/15|
|kidney|11/21|
|liver|7/20|
|lung|28/75|
|lymphocyte|7/14|
|ovary|10/26|
|pancreas|11/24|
|peripheral nervous system|11/16|
|plasma cell|11/15|
|prostate|1/1|
|skin|13/24|
|soft tissue|4/7|
|thyroid|0/2|
|upper aerodigestive|9/22|
|urinary tract|6/29|
|uterus|4/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 7210
* **Expression level (log2 read counts)**: -2.79
{{:chemogenomics:nalm6 dist.png?nolink |}}